Trial Profile
The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 20 Sep 2012
Price :
$35
*
At a glance
- Drugs Sertindole (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- 01 Aug 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 19 Sep 2011 Planned end date changed from 1 Aug 2011 to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 19 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.